Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,727 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

NCT05960708

Conditions
Allergic Disease, Chronic Disease, Chronic Inducible Urticaria, +13 more
Locations
  • Hallym University Sacred Heart Hospital Anyang-si, Gyeonggi-do, South Korea
  • Hallym University Dongtan Sacred Heart Hospital Hwaseong-si, Gyeonggi-do, South Korea
  • CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
View Trial Details
Completed

Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy

NCT02223182

Conditions
Food Allergy, Food Hypersensitivity, Hypersensitivity, +3 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rady Children's Hospital San Diego, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment

NCT03059992

Conditions
Allergic Bronchopulmonary Aspergillosis, Aspergillosis, Aspergillosis, Allergic Bronchopulmonary, +44 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
View all 37 locations
View Trial Details
Completed

Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants

NCT05430919

Conditions
Allergic Rhinitis, Conjunctival Diseases, Conjunctivitis, +10 more
Locations
  • Kingston General Health Research Institute Kingston, Ontario, Canada
  • Inflamax Research Limited DBA Cliantha Research Mississauga, Ontario, Canada
  • Clinique Specialisee en Allergie de la Capitale Québec, Quebec, Canada
View Trial Details

Related conditions